Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry
Egeberg, A., Iversen, L., Gniadecki, R., Hvid, L., Dam, T.N., Bryld, L.E., Skov, L.Language:
english
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.14200
Date:
March, 2017
File:
PDF, 120 KB
english, 2017